Biossimilares ampliam acesso | Abbott Newsroom
Abbott Laboratories · Company update · December 17, 2025
Abbott published an article discussing the role of biosimilar medicines in expanding healthcare access in Brazil, highlighting their cost-effectiveness and safety for treating complex conditions like cancer.
AntSpace’s summary of Abbott Laboratories’s own announcement: read the original.